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Abstract
Traditional genetic association studies are very difficult in bacteria, as the generally limited recombination leads to large
linked haplotype blocks, confounding the identification of causative variants. Beta-lactam antibiotic resistance in
Streptococcus pneumoniae arises readily as the bacteria can quickly incorporate DNA fragments encompassing variants that
make the transformed strains resistant. However, the causative mutations themselves are embedded within larger
recombined blocks, and previous studies have only analysed a limited number of isolates, leading to the description of
‘‘mosaic genes’’ as being responsible for resistance. By comparing a large number of genomes of beta-lactam susceptible
and non-susceptible strains, the high frequency of recombination should break up these haplotype blocks and allow the use
of genetic association approaches to identify individual causative variants. Here, we performed a genome-wide association
study to identify single nucleotide polymorphisms (SNPs) and indels that could confer beta-lactam non-susceptibility using
3,085 Thai and 616 USA pneumococcal isolates as independent datasets for the variant discovery. The large sample sizes
allowed us to narrow the source of beta-lactam non-susceptibility from long recombinant fragments down to much smaller
loci comprised of discrete or linked SNPs. While some loci appear to be universal resistance determinants, contributing
equally to non-susceptibility for at least two classes of beta-lactam antibiotics, some play a larger role in resistance to
particular antibiotics. All of the identified loci have a highly non-uniform distribution in the populations. They are enriched
not only in vaccine-targeted, but also non-vaccine-targeted lineages, which may raise clinical concerns. Identification of
single nucleotide polymorphisms underlying resistance will be essential for future use of genome sequencing to predict
antibiotic sensitivity in clinical microbiology.
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Introduction
Recent research aimed at finding the genetic causes of beta-
lactam resistance in Streptococcus pneumoniae has been focused on
laboratory mutagenesis [1–4], sequence comparison [1,5,6], and
identification of interspecies sequence transfer that promotes
penicillin non-susceptibility [7–10]. Though these studies have
increased our understanding, their resolution is limited, and a
whole-genome systematic search in real population settings is still
lacking. Indicative of this limited resolution is the frequent use of
the term ‘‘mosaic genes’’ to describe pneumococcal resistance
alleles [7]. Although recombinational mosaics are clearly identi-
fiable as regions of several hundred nucleotides in resistance genes,
it is likely that only a subset of the observed alterations are
important in causing resistance. Genome wide association studies
(GWAS) have been used to identify genetic loci associated with
complex diseases ranging from cancer to mental illness in human
populations [11–13]. While the method should, in theory, be
applicable to bacterial populations, its use has been inhibited by
significant difficulties. These are primarily due to the clonal
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population structure, and generally limited recombination within
bacteria, which make the causal SNPs indistinguishable from other
linked SNPs, effectively creating very large haplotype blocks
[14,15]. Attempts have been made to take this clonal structure into
account in association analyses [16,17], but strong linkage
disequilibrium will always restrict the resolution of the approach.
To overcome this, studies will require either populations with
elevated recombination, a large diverse sample, or both, to make
the statistical analysis robust.
The confounding effect from clonal population structure may be
less problematic in highly recombinogenic bacteria. Homologous
recombination brings genetic admixture into bacterial populations
in a manner akin to sexual reproduction in humans, although it
does not occur every generation, and only affects a small part of
the genome in each occurrence. In S. pneumoniae, homologous
recombination involves, on average, 2.3 kb of chromosomal DNA
[18], about twice the size of an average pneumococcal gene,
suggesting that large numbers of recombinational events must
accumulate in order to break up linkage blocks smaller than this
size. However, the recombination signals left after the action of
natural selection are not uniformly distributed across the genome
but are concentrated at particular loci, which are commonly
known as recombination hotspots. These hotspots are coincident
with genes involving the bacterial response to selection pressure,
which includes host immune responses and antibiotic utilization,
particularly beta-lactams [19,20]. We hypothesized that the
frequency of recombination at these sites would therefore be
sufficient to allow the identification of causal SNPs associated with
resistance to beta-lactams, given a large enough sample size.
Continuing reduction in sequencing costs has allowed the scale of
whole-genome bacterial population studies to increase [20,21],
and this should provide more robust statistical power for
association analyses. The availability of multiple large bacterial
population studies allows a replication of such association studies,
providing stronger evidence for common causal SNPs as well as
the potential to identify rarer causal SNPs, some of which might
only be detected in unique population settings.
Here we conducted an association study using the pneumococ-
cal populations from carriage cohorts in Maela refugee camp,
Thailand [20], and Massachusetts, USA [21], two recent species-
wide pneumococcal studies from which large numbers of whole
genome sequences and phenotypes for beta-lactam susceptibility
are available. Given the high recombination frequency in S.
pneumoniae generally, the observed recombination hotspots
covering antibiotic resistance genes, and the relatively large
sample sizes of both studies, we hoped to overcome the challenges
in performing bacterial association studies discussed above.
Therefore this study aimed to more precisely identify the sets of
variants associated with resistance, where they were located in the
genome, and how they were distributed across the population.
Results
Identification of loci associated with beta-lactam non-
susceptibility
We conducted an association study on whole genome SNPs and
insertions or deletions (indels) to identify variants associated with
beta-lactam non-susceptibility. Two rounds of analyses were
performed separately using 3,085 genomes from pneumococcal
strains collected from a carriage cohort in Maela [20], and 616
genomes from a carriage cohort from Massachusetts [21]. Based
on the Clinical and Laboratory Standard Institute guidelines
(CLSI, 2008), strains with penicillin minimum inhibitory concen-
tration (MIC) #0.06 mg/ml were classified as susceptible; applying
these cutoffs to our data gave 1,729 case (non-susceptible) and
1,951 control (susceptible) samples for our study (with 21
unknown). The Maela and Massachusetts populations comprise
strains from multi-lineage backgrounds. Therefore, taking the
population stratification into account is essential to separate the
clonal population signals from true phenotypic associations. The
population substructures utilized were those defined previously
[20,21], which in both cases were determined using a Bayesian
clustering approach (see Methods). Based on this clustering
information, the Cochran-Mantel-Haenszel (CMH) association
statistic was employed to test for associations between beta-lactam
non-susceptibility and specific variants, conditional on the
population cluster. For each population, we screened for common
alterations with minor allele frequency .0.01 and reported sites
with a p value,0.01, incorporating a Bonferroni adjustment for
multiple comparisons (Figure 1, Tables S1–S3).
We found 858 and 1,721 SNPs associated with beta-lactam
non-susceptibility in the Maela and Massachusetts populations
respectively (Figure 2, Tables S2–S3). Among these, 301 SNPs
were found to be associated with non-susceptibility in both
populations. Considering that the two settings have different
population structures that have evolved independently, these co-
detected SNPs represent a set of candidates in which we can have
more confidence. Rather counter-intuitively, more candidate
SNPs were identified in the smaller dataset from Massachusetts
than in the larger dataset from Maela. There are several potential
explanations for this observation; one being that it is due to
different linkage structure within the two datasets. Not all of the
candidate SNPs will necessarily play a causative role; some may be
tightly linked to causative SNPs, with insufficient recombination in
the dataset to separate them (here called ‘‘hitchhiking’’ SNPs), and
hence form part of the same haplotypes. To test this, we estimated
the size of the haplotype blocks that harbor candidate SNPs in
both the Maela and Massachusetts populations, using the criteria
described in Gabriel et al. [22,23] (see Methods). Haplotype block
Author Summary
Streptococcus pneumoniae is carried asymptomatically in
the nasopharyngeal tract. However, it is capable of causing
multiple diseases, including pneumonia, bacteraemia and
meningitis, which are common causes of morbidity and
mortality in young children. Antibiotic treatment has
become more difficult, especially that involving the group
of beta-lactam antibiotics where resistance has developed
rapidly. The organism is known to be highly recombino-
genic, and this allows variants conferring beta-lactam
resistance to be readily introduced into the genome.
Identification of the specific genetic determinants of beta-
lactam resistance is essential to understand both the
mechanism of resistance and the spread of resistant
variants in the pneumococcal population. Here, we
performed a genome-wide association study on 3,701
isolates collected from two different locations and identi-
fied candidate variants that may explain beta-lactam
resistance as well as discriminating potential genetic
hitchhiking variants from potential causative variants. We
report 51 loci, containing 301 SNPs, that are associated
with beta-lactam non-susceptibility. 71 out of 301 poly-
morphic changes result in amino acid alterations, 28 of
which have been reported previously. Understanding the
determinants of resistance at the single nucleotide level
will be important for the future use of sequence data to
predict resistance in the clinical setting.
B-lactam Resistant Determinants from Pneumococcal Association Study
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sizes detected in the Maela data are significantly smaller than the
Massachusetts data (Mann Whitney test p value 6.5361029,
Figure S1), indicating that many of the candidate SNPs detected
in the Massachusetts data are potential hitchhikers, thereby
generating some false positive results. The second potential
explanation is due to the population stratification defined
previously [20,21]. As the clustering analyses were performed
separately on each dataset, it is possible that the clustering
information from the two datasets are not equivalent in their
stringency, leading to a more strict control over population
stratification in one population than the other. Nevertheless, 51
candidate loci, comprising a total of 301 discrete and linked SNPs,
were co-detected in both the Maela and Massachusetts data; using
these should provide a high-stringency data set that overcomes
these population-specific effects. The co-detected loci include three
intergenic SNPs, and 298 SNPs detected in coding sequences. The
latter can be divided into 71 non-synonymous and 227 synony-
mous SNPs. Of these 51 loci, nine were single SNPs, and 42 were
in linkage blocks of between two and 19 SNPs, of which 12
contained only a single non-synonymous SNP. Based on
assembled sequences, we also investigated whether or not indels
found in associated genes could contribute to the resistant
phenotype. None of the identified indels showed significant
association with resistance, after Bonferroni correction, at a p-
value of ,0.01.
To estimate how much of the phenotypic resistance in our
samples could be explained by the identified SNPs, we performed
cross-prediction tests using only the SNPs co-detected in both the
Maela and Massachusetts association studies, tested back against
each population separately. We found that close to 100% of the
resistance in each population could be explained by all of the co-
detected SNPs (Figure S2). Unlike human polygenic traits where
each locus contributes only a small effect on the phenotype, each of
these bacterial loci appears to have a much stronger effect, and
indeed some have been shown experimentally to change the
phenotype with only a single variant [1]. This can be demonstrated
using odds ratios, which indicate the size of the effect of each
associated SNP. While human GWAS studies report a median odds
ratio of 1.33 per SNP [24,25], our analysis gives a median odds ratio
of 11.09 per SNP, indicating a stronger effect size. For both the
Figure 1. Summary of the genome-wide-association study conducted in two separate datasets. Manhattan plots summarize the
association of whole-genome SNP variants with beta-lactam susceptibility in the Maela and Massachusetts data as well as particular gene regions
which show strong associations. Top panel represents the statistical significance of association (y-axis) for each variant arranged in order on the
genome (x-axis) in the Maela (red) and Massachusetts (blue) data. Horizontal dotted lines in both top and bottom panels indicate a significance cut-
off after Bonferroni correction of p = 0.01. Genes with significant associations are annotated on top. Genes coding for penicillin binding proteins:
pbp2x, pbp1a, and pbp2b, whose roles in beta-lactam resistance are well characterized, are highlighted in grey. Bottom panel expands the view of
penicillin binding protein genes where most of the significant associations are detected: from left to right: pbp2x, pbp1a, and pbp2b. Protein domains
identified within these genes are shaded in pale grey and labelled. The vertical dotted lines represent the active sites of the transpeptidase domain.
Plus signs denote synonymous SNPs and dots denote non-synonymous SNPs.
doi:10.1371/journal.pgen.1004547.g001
B-lactam Resistant Determinants from Pneumococcal Association Study
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Maela and Massachusetts populations, the percentage of resistance
explained plateaued after the addition of approximately 10 loci in
any order. This suggests that, at most, about 10 loci are required to
make a susceptible strain non-susceptible and that multiple different
combinations can achieve this. However, in each resistant isolate,
combinations of more than ten loci are commonly detected, perhaps
indicating that not all loci are involved in conferring resistance, but
that some may play a compensatory role in reducing the fitness cost
of resistance variants. In total, the co-detected variants are present
in 100% and 98% of the Maela and Massachusetts resistant strains
respectively, highlighting that a large proportion of possible
resistance variants are captured in our study.
Biological relevance of candidate loci
For both population settings, loci found to be associated with
beta-lactam non-susceptibility show higher enrichment in genes
compared to intergenic regions than would be expected by chance
(Fisher’s Exact Test p-value,0.0001). Candidate loci are not
randomly distributed across the whole genome, but clustered
within certain genes (Figure 1). Co-detected loci in both datasets
are localized in genes participating in the peptidoglycan biosyn-
thesis pathway, including penicillin binding proteins (pbp2x,
pbp1a, pbp2b) and two transferases required for cell wall biogenesis
(mraW, mraY), the cell division pathway (ftsL, gpsB), heat shock
protein and chaperones (clpL, clpX), the recombination pathway
(recU) and a metabolic gene known to confer resistance to co-
trimoxazole (dhfR). Some of these sites, particularly in the pbp
genes, matched those previously reported to play an important
role in beta-lactam resistance in the literature (Table S1). To our
knowledge, out of 71 non-synonymous SNPs reported here, 43
SNPs are novel and potentially contribute to beta-lactam non-
susceptibility in addition to those identified in previous studies.
Candidate loci in genes participating in the
peptidoglycan biosynthesis pathway
Since most beta-lactam antibiotics work by inhibiting cell wall
biosynthesis, it is not surprising to see significant associations
between non-susceptible phenotypes and variants in genes
participating in the peptidoglycan biosynthesis pathway, including
pbp2x, pbp1a, pbp2b, mraW and mraY. Many single amino acid
alterations in pbp2x, pbp1a and pbp2b have been previously
demonstrated experimentally to increase pneumococcal resistance
to beta-lactams. Mutations within or close to the active sites of the
transpeptidase domain in penicillin binding proteins have been
reported to be associated with penicillin resistance [26–28]. By
interfering with the formation of a covalent complex between the
active site serine and antibiotic molecules, these mutations help
reduce the binding affinity of beta-lactam rings to the transpep-
tidase enzyme. This allows the pneumococci to form a functional
cell wall, and thereby become non-susceptible. We observed many
predicted loci co-localizing with or surrounding the transpeptidase
active sites. These are recognized as three conserved amino acid
motifs, SXXK, SXN and KT(S)G [1,29] and are highlighted as
vertical dotted lines in the bottom panel of Figure 1. Many
known structurally characterized alterations in pbp genes have
been rediscovered in our analysis, providing independent valida-
tion of some of our results. In pbp2x, we observed an association at
T338A, which is located next to the active site 337. The side chain
of T338 is required for hydrogen-bonding, and the T338A
substitution results in a distortion of the active site [1]. In pbp1a,
an alteration from TSQF to NTGY at position 574, which has
been shown to have a lower acylation efficiency in vitro [1,30],
was also observed in this analysis. In addition to candidates known
to confer structural changes that lead to resistance, we also
observed association with E285Q in pbp1a which might contribute
to a fitness compensation mechanism caused by resistance in
pbp2b [31]. Other functional conformational changes, as well as
variants that matched previous observations from sequence
comparison, are tabulated in Table S1 [1,2,5,6,30–38]. More-
over, we observed substitutions outside pbp genes that could
potentially affect antibiotic susceptibility, or represent compensa-
tory mutations that interact epistatically with changes associated
with resistance. These include the genes mraY and mraW, which
encode transferases. Both function upstream of the pbp genes in
the peptidoglycan biosynthesis pathway.
Figure 2. Summary of single nucleotide polymorphisms (SNPs) associated with beta-lactam non-susceptibility. A Venn diagram
summarises the number of SNPs reaching significance in each of the Maela and Massachusetts datasets, and those that are co-detected in both.
doi:10.1371/journal.pgen.1004547.g002
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Candidate loci in genes outside the peptidoglycan
biosynthesis pathway
The genome-wide screen provided us with an opportunity to
identify associations outside the pbp genes and the peptidoglycan
biosynthesis pathway, which are the direct target of beta-lactams.
In both the Maela and Massachusetts datasets, nine independent
loci comprising 31 SNPs were detected outside of these pathways.
These include amino acid alterations in a major heatshock protein,
clpL. Mutants lacking clpL have been previously reported to be
more susceptible to penicillin [1]. The effect was attributed to the
ability of clpL to interact with and stabilize the Pbp2x protein. In
the Massachusetts data alone, we observed associations between
resistance and ciaH, a histidine kinase sensor, and ciaR, its
response regulator, consistent with previous studies reporting a
large increase in resistance due to ciaH mutations. The mutations
in the ciaH kinase sensor resulted in hyperactivation of the ciaR
regulator, which in turn leads to increased beta-lactam resistance
[1,39]. Association signals from ftsL and gpsB genes were detected
in both datasets. These two genes function in cell division and are
essential for complete cell wall formation. Depletion of GpsB leads
to cell deformation with a similar phenotype to that observed
when the Pbp2x protein is inhibited by methicillin [40]. These
identified candidates potentially interact with pbp genes, either
directly or indirectly through regulation or participation in cell
wall formation; however, experimental characterization will be
required to explore the mechanisms of how these alterations
influence beta-lactam susceptibility.
Candidate loci in genes conferring resistance to other
antibiotics
Interestingly, strong discrete associations were also found in
genes where specific variants are known to confer resistance to co-
trimoxazole, an antibiotic targeting the bacterial DNA synthesis
pathway [41]. We detected associations in dhfR (encoding
dihydrofolate reductase) and folP (dihydropteroate synthase),
which are required for folate synthesis and are essential for
nucleotide biosynthesis. Given that beta-lactam and trimethoprim
resistance arise from different mechanisms and that the dhfR and
folP loci are not genetically linked to any other detected loci, it is
curious as to why we observed these signals. A possible explanation
could be the contemporaneous use of both beta-lactam and
trimethoprim antibiotics in the host populations studied, which
would drive co-selection for resistance to the two unrelated classes
of antibiotics. In both the Maela and Massachusetts datasets,
strains that are phenotypically resistant to beta-lactams are more
likely to be phenotypically resistant to co-trimoxazole, suggesting
that the two phenotypes did not occur independently (Fisher’s
exact test p-value,2.2610216, Table 1). Clinical records from
Thailand listed beta-lactams and co-trimoxazole as the first and
second most frequently prescribed antibiotics for upper respiratory
infection treatments [42], indicating that co-selection pressures
may have been possible if the two antibiotics were frequently used
together.
Beta-lactam specificity of resistance mutations
As some of the variants detected by our study are known to
affect the binding affinity for beta-lactams, we looked to see
whether the effect would be equivalent across all classes of beta-
lactam antibiotics, or if resistance due to specific variants would be
greater for certain classes of antibiotic. To test this, we replicated
the analysis on the candidate loci using the continuous phenotype
of the minimum inhibitory concentration (MIC) value for two
classes of beta-lactam antibiotics; penicillins and cephalosporins
(here represented by ceftriaxone). Penicillins and cephalosporins
both possess a characteristic beta-lactam ring, but while the beta-
lactam ring is fused to a 5-membered thiazolidine ring in
penicillins, it is fused to a 6-membered dihydrothiazine ring in
cephalosporins. The drugs also differ in side chains that
differentiate their kinetic properties [43]. Figure 3 plots the
differential association of each locus to the two beta-lactam
antibiotics. Loci with stronger association towards penicillin are
distributed along the positive y-axis, while those showing a
stronger preference towards cephalosporins are distributed along
negative y-axis. We found that loci do not contribute equally to
different classes of beta-lactam antibiotics (Kruskal-Wallis rank
sum test, p value,2.2610216), with a strong association of some
loci towards resistance to either penicillins or cephalosporins.
Distribution of candidate alleles in the Maela and
Massachusetts populations
Given the known pneumococcal population structure in both
the Maela and Massachusetts datasets [20,21], we sought to
explore and compare the prevalence of candidate beta-lactam
resistance alleles identified as loci co-detected in the two
populations. The two populations are composed of multiple
pneumococcal lineages, many of which are present in one
population but absent in the other. This difference in population
structure has a large influence on the types of resistance alleles
detected in each setting. Therefore, an unbiased comparison
between the Maela and Massachusetts populations can only be
made using the lineages common to both locations. PMEN-14, the
globally dispersed multidrug resistant lineage, was detected in both
Table 1. Co-occurrence of co-trimoxazole and beta-lactam resistance phenotypes.
Beta-lactam
Fisher’s exact test p-
value and (odds ratio)
resistant sensitive
Maela Co-trimoxazole resistant 1,356 771 ,2.2610216 (10.36)
intermediate 77 280
sensitive 68 517
Massachusetts resistant 102 38 ,2.2610216 (7.29)
sensitive 125 341
Note that the association is significant for the Maela data regardless of how co-trimoxazole resistant and intermediate strains were grouped. Grouping co-trimoxazole
intermediate and sensitive strains together still gives a significant association with p-value ,2.2610216 with odds ratio 9.66. Isolates with missing phenotypes were
removed from this analysis.
doi:10.1371/journal.pgen.1004547.t001
B-lactam Resistant Determinants from Pneumococcal Association Study
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populations (Maela: 2007–2010, Massachusetts 2001–2007), and
thus allows a comparative view between the two datasets. PMEN-
14 isolates from Maela and Massachusetts have significantly
different beta-lactam resistance allelic profiles (Mann-Whitney U
test, p value = 4.68610212).
Though the local beta-lactam resistance profiles are different,
the pattern of their distribution across the Maela and Massachu-
setts pneumococci is similar. In both populations, the distribution
of resistance alleles is not uniform (Figure 4). The multidrug
resistant lineages PMEN-14 and PMEN-1, along with other
vaccine target lineages appear to carry predicted resistance alleles
at a higher frequency. This reflects the vaccine’s design to target
serotypes associated with antibiotic resistance [21,44]. However,
levels of beta-lactam resistance have generally remained stable
post-vaccine introduction [21,45,46], which has resulted from the
success of resistant non-vaccine lineages with a high frequency of
resistance alleles (e.g. 35B in Massachusetts, NT in Maela;
Figure 4) and serotype switching by resistant-vaccine type
lineages such as PMEN-14 [21]. In pneumococcal populations
dominated by NT lineages such as in Maela, the higher rate of
recombination observed in these lineages [20], and the fact that
they are not targeted by current vaccines, may allow them to act as
both source and sink for resistance alleles, generating more
combinations that are then seeded into the wider population.
Discussion
The power of phenotype-genotype association studies in bacteria
is limited by the clonal population structure and limited recombi-
nation within these organisms. One approach to overcoming this is
to explicitly account for population structure in the analysis, and this
was recently attempted for studies of host-association in Campylo-
bacter [16] and Staphylococcus aureus [17], but the sensitivity of
both was limited by a relatively small sample size. Our analysis used
Figure 3. Specificity of association signals for co-detected candidate loci with different classes of beta-lactam antibiotics. Bonferroni-
adjusted p-values from associations with continuous phenotypes with each co-detected SNP were grouped into their linkage loci. Positive values on
the y-axis show stronger association with penicillin resistance while negative values show stronger association with cephalosporin resistance.
Horizontal dotted lines represent the 99th percentile.
doi:10.1371/journal.pgen.1004547.g003
B-lactam Resistant Determinants from Pneumococcal Association Study
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Figure 4. Frequency of putative resistance alleles from candidate loci in the Maela and Massachusetts populations. The resistant allele
frequency at each locus (rows) in each population cluster (columns) is represented by different shades on a blue-grey scale. Vaccine and non-vaccine
serotype status of each cluster are shown at the top of each column. Asterisks highlight two drug resistant global clones: * represents the PMEN1
lineage; ** represents the PMEN14 lineage. Note that mixed population clusters have been removed from the diagram.
doi:10.1371/journal.pgen.1004547.g004
B-lactam Resistant Determinants from Pneumococcal Association Study
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a S. pneumoniae data set of much larger size, enhancing statistical
power in detecting associated variants. Our approach also took
advantage of the higher level of recombination in the genes
participating in the peptidoglycan biosynthesis pathway, some of
which are known to be recombination hotspots [19,20] significantly
reducing the effect of long haplotype blocks within these important
genes. Together, this enabled us to identify specific nucleotide
variants underlying beta-lactam resistance in this organism, some of
which were previously known, but many of which are novel.
Our analysis allows the refinement of the understanding of
resistance beyond ‘‘mosaic genes’’ to identify likely causative
variants, and shows that there are multiple loci which may
contribute to resistance. We have also been able to show that,
while some loci likely contribute universally to all beta-lactam
resistance, some can demonstrate a stronger association with
resistance to certain classes of antibiotics more than others.
We used this resistance variant dataset to examine the allele
distribution within the sampled population. While specific lineages
can vary between populations in the resistance loci present, a
general finding was that a high frequency of resistance alleles could
be found in both vaccine and non-vaccine lineages, a potential
explanation for why vaccination has not reduced beta-lactam
resistance within the population. Some non-vaccine target lineages
with a high frequency of resistant alleles can act as both a source
and a sink of resistance alleles within the population.
A limitation of our approach is that it is sensitive to
recombination frequency and requires a non-clonal population
and a large sample size. Although the recombination frequency of
different bacteria is relatively fixed, current sequencing technol-
ogies do now allow very high sample sizes within bacterial
populations, and this may increase the applicability of this
approach in the future. The sensitivity of detection of association
will also be enhanced by the occurrence of de-novo mutations
conferring resistance (homoplasy; [19]), representing convergent
evolution. However, this will only be possible using whole-genome
sequencing, and these could not be detected by eukaryotic-style
marker-SNP-based association studies.
Future use of whole-genome sequencing for antibiotic resis-
tance/sensitivity prediction in clinical practice will rely on the
ability to assign function to specific variants, rather than mosaic
blocks, and this kind of study will be essential to enable these future
applications. Nevertheless, results reported from this genome-wide
association study are hypothesis-generating and will require
further functional validation.
Materials and Methods
Phenotype and genotype data
The test populations represent the largest datasets for which
whole genome sequences and antibiotic-resistance phenotypes are
available - Maela [20] and Massachusetts [21]. Beta-lactam
susceptibilities were determined in both datasets by disk diffusion
following the CLSI 2008 guidelines [47]. Our analyses contained
1,501 non-susceptible, 1,568 susceptible and 16 unknown pheno-
types in the Maela data; 228 non-susceptible, 383 susceptible and 5
unknown phenotypes from the Massachusetts data. The minimum
inhibitory concentrations (MIC) of non-susceptible isolates were
confirmed by the E-test method (bioMerieux, Marcy L’Etoile,
France). Strain names and a full list of MICs from the Maela dataset
[20] are given in Table S4. Strains and metadata for the
Massachusetts dataset were given as supplementary data in ref [21].
Samples were previously sequenced as multiplexed libraries on
Illumina Hiseq 2000 machines using 75-nt or 100 nt paired-end
runs as described in [20,21]. Short reads from both studies have
previously been deposited in the European Nucleotide Archive
under study number: Maela data - ERP000435, ERP000483,
ERP000485, ERP000487, ERP000598 and ERP000599; and
Massachusetts data as listed in Table S1 of [21]. Reads from both
datasets were mapped onto a single reference genome, S.
pneumoniae ATCC 700669 (European Molecular Laboratory
(EMBL) accession FM211187) [48] using SMALT 0.5.7. (http://
www.sanger.ac.uk/resources/software/smalt/). Bases were called
from mapped sequences using the methods described in [49],
resulting in 392,524 and 198,248 SNP calls from the Maela and
Massachusetts data respectively. Genomes from Maela were de
novo assembled using Velvet [50] with combinations of SSPACE
[51], GapFiller [52], BWA [53] and Bowtie [54] as in [20] and
genomes from Massachusetts were assembled with Velvet exclu-
sively as described in [21]. Assembled sequences allowed variations
from insertions and deletions (indels) to be incorporated for a
deeper analysis at each locus.
Defining population structure
The Maela and Massachusetts populations represent species-wide
data sets; they respectively consist of 65 and 46 different capsule types,
and at least 277 and 154 known multilocus sequence types. The
population substructures as determined in [20] [21] were used in this
analysis. Briefly, whole genome-mapped sequences and concatenated
core genome sequences were used in the Maela [20] and
Massachusetts data [21], respectively, as input to the BAPS software
[55–57]. BAPS was used to define the clonal population structure by
estimating the structure based on non-reversible stochastic optimiza-
tion. The method has successfully been applied to bacterial
populations of several different species [58,59]. Individual strains in
Maela and Massachusetts data were first partitioned into clusters
based on multiple runs of the estimation algorithm (Methods in
[20][21]). This resulted in 33 and 16 initial clusters for the Maela and
Massachusetts data, respectively. Due to the large sample size of the
Maela dataset, BAPS was additionally run in a hierarchical manner.
As described in [20], data from each of the primary clusters identified
in the Maela data were re-analyzed to obtain secondary clusters
within each primary cluster, and these were used to represent the
population structure of Maela pneumococci.
Quality control
The haploid bacterial SNP information was treated as human
mitochondrial sequence in PLINK v. 1.07 [60] and controlled for
missing rate and allele frequency. We excluded variants with
minor allele frequency ,0.01, missingness by strain .0.1 and
missingness by variants .0.1. For each site, the top two most
common variants were parsed to the next analysis to reduce
complexity in the test statistic.
Simulation on case-control association analysis
Intrinsic noise from genetic variation alone can lead to false
positive signals. To estimate basal false positive rates and decide a
suitable cut-off for each dataset, we separately ran 100 GWAS
permutations with true genotypes but randomized binary pheno-
types (Figure S3). None of the permutations of either the Maela
or Massachusetts datasets achieved any significant association at p-
value 0.01 with a Bonferroni correction for multiple testing,
therefore validating a Bonferroni-adjusted cut-off at p-value 0.01
as our conservative threshold.
Case-control association analysis with real data
We first determined SNPs associated with beta-lactam resis-
tance with binary phenotypes: susceptible or non-susceptible.
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However, the intrinsic clonal population structure of bacteria can
result in high false positive rate in GWAS. The tests were thus
performed conditioned on the population structure generated by
BAPS in previous publications [20,21] and controlled for genomic
inflation factor. Based on known cluster information, the Cochran-
Mantel-Haenszel (CMH) test for 2626K binary phenotype x
variants | population cluster was employed with sites corrected for
multiple testing using the Bonferroni correction at a p-value of
0.01. The application of the CMH test reduced the genomic
inflation factor from 80.16 (mean chi-squared statistic = 68.99) to
2.56 (mean chi-squared statistic = 3.05) in the Maela data, and
13.18 (mean chi-squared statistic = 14.17) to 3.76 (mean chi-
squared statistic = 4.73) in the Massachusetts data. The reductions
in genomic inflation factor seen in both datasets suggest a decrease
in false positive rates due to underlying population structure.
However, the genomic inflation factors observed here are
relatively high compared to those observed in human nuclear
chromosome GWAS, suggesting that intrinsic clonal population
structure is still an issue for bacterial association studies.
Testing the effect of cluster size of the population
stratification
Genome wide association studies are sensitive to population
stratification. While a stringent stratification helps reduce false
positives, it potentially increases false negatives. Due to the size of
the Maela dataset, we had available the (more relaxed) primary
BAPS clusters, and the (more stringent) secondary BAPS clusters,
and we therefore used these to investigate the effect of clustering
size with respect to the number of discovered variants and false
positive rate in our data. We separately repeated the Cochran-
Mantel-Haenszel (CMH) test as described above using information
on primary and secondary BAPS clusters as previously defined
[20]. We detected greater numbers of variants with significant
associations when stratified by primary clusters compared to
secondary clusters (10,451 SNPs compared to 858 SNPs). Also, a
higher false positive rate was observed in the analyses using the
primary clusters than the secondary clusters (genomic inflation
factor of 6.58 compared to 2.56). This result is consistent with
what is expected, reflecting a trade-off between false positives and
false negatives, and will be dependent on the sample size and
underlying population structure.
Linkage analysis
A high genomic inflation factor indicated that some of the
candidate alleles were influenced by population structure and were
likely to be hitchhikers. We explicitly tested for linkage disequi-
librium between candidate SNPs using Haploview version 4.2
[61]. The information was treated as male human X-chromosome
to retain its haploidy. Haploview was devised for human genetics
where linkages between distant sites are disrupted by crossing-
over. Unlike human, bacterial recombination does not necessarily
break long distance linkage. We therefore set Haploview to
consider all pairwise comparisons under 2,200 kb, which is the size
of the whole S. pneumoniae genome, thus incorporating all
possible linkage predictions into our analysis. Using 95%
confidence bounds as described in [22], a haplotype block was
identified as a region with a low recombination rate (Figure S4).
These linkage blocks were used to show the context of the
predicted alleles and thus potential limitations of our study. We
also compared physical linkage size (Figure S1) detected in the
Maela and Massachusetts data. The smaller linkage blocks found
in the Maela data suggest a higher likelihood of capturing
recombination in the larger dataset and thus separating causative
SNPs from hitchhiking SNPs.
Estimation of percent resistance in the population that
can be explained by the candidate loci
We plotted the proportion of resistance in the population that
could be explained by the co-detected loci in each of the test
populations, using only combinations of variants observed in both
theMaela andMassachusetts datasets (Figure S2). The order of loci
added was permutated to accommodate all possible combinations.
Specificity to different classes of beta-lactams
To test whether or not there were variants conferring more
specific resistance to certain classes of beta-lactam antibiotics, we
repeated the analysis on co-detected candidate SNPs in both
datasets and replaced the binary phenotypes with continuous
phenotypes: penicillin MIC values and ceftriaxone MIC values. P-
values calculated from penicillin MIC and ceftriaxone MIC for
each SNP were grouped by the linkage structure.
Prevalence of candidate loci in the population
For each BAPS cluster in both the Maela and Massachusetts
data, we calculated the mean prevalence of candidate loci by
averaging the frequency of linked SNPs detected in each locus per
cluster size.
All statistical analysis were performed in PLINK version 1.07 and
R version 2.11.1. Graphical representations were created in R.
Supporting Information
Figure S1 Summary of physical linkage structure in two separate
datasets. Size of linkage loci detected in the Maela (red) and
Massachusetts (blue) association studies were plotted as histograms
on log10 scale. Vertical dotted lines mark the median size of
haplotype blocks that harbor candidate SNPs (37.5 bp in the
Maela data and 165 bp in the Massachusetts data).
(EPS)
Figure S2 Percentage of the non-susceptible phenotype ex-
plained by co-detected loci in the Maela and Massachusetts
populations. The plots represent proportions of resistance in the
population (y-axis) explained by all combinations of increasing
numbers of co-detected loci (x-axis), based on combinations of loci
observed from both the Maela and Massachusetts data.
(EPS)
Figure S3 Randomised control for intrinsic noise based on
genetic variation alone. Manhattan plots (see legend to Fig. 1)
demonstrate no significant associations in either Maela or
Massachusetts data using real genotype data and randomized
resistance phenotype assignments. Horizontal dotted lines mark
the cutoff with Bonferroni correction at p = 0.01.
(EPS)
Figure S4 Linkage analysis for variants co-detected in two
separate datasets. The Haploview plot illustrates linkage disequi-
librium (r2) between co-detected SNP candidates from the Maela
and Massachusetts datasets. The bar on the left represents the
genome position of the SNPs, connected by lines to the diamond
plot, right. A complete black diamond represents complete linkage
disequilibrium between candidate SNPs (r2 = 1), while a white
diamond represents a perfect equilibrium (no linkage) (r2 = 0).
(EPS)
Table S1 Associations co-detected in two separate datasets. The
table summarizes all association statistics, linkage disequilibrium
(LD) analysis, biological relevance and literature references for co-
detected SNPs and associated loci in the Maela and Massachusetts
data. From left to right, the columns represent coordinates from
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the reference genome (S. pneumoniae ATCC 700669), coding
regions in which associations were detected, putative resistance
nucleotide alleles, putative sensitivity nucleotide alleles, minor
allele frequency (MAF), odds ratios (OR), synonymous and non-
synonymous changes, positions on protein sequences with
observed amino acid alterations, amino acid residues, alternative
amino acid residues, literature reports, PubMed identifier (PMID),
and linkage information.
(XLS)
Table S2 Associations detected in the Maela data. The table
summarizes all association statistics and linkage disequilibrium (LD)
analyses for variations that show significant associations in the
Maela data. From left to right, the columns represent coordinate
from the reference genome (S. pneumoniae ATCC 700669),
majority detected SNPs, minor allele frequency, minor detected
SNPs, odd ratios, linkage information and gene information.
(XLS)
Table S3 Associations detected in the Massachusetts data.
Summary of all association statistics and LD analysis for variations
that show significant association in Massachusetts data. Columns
were summarized using the same scheme described in Table S2.
(XLS)
Table S4 Additional strain information for beta-lactam suscep-
tible and non-susceptible phenotypes for the Maela dataset.
Susceptibilities were determined by disk diffusion with oxacillin
(1 mg oxacillin disk zone diameter of ,20 mm). Minimum
inhibitory concentration (MIC) values were determined by E-test
if disk diffusion test indicated potential penicillin non-susceptibility
[20].
(XLS)
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